Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Core EBITDA Growth

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.6827.6932.55-13.1679.82

What is the latest Core EBITDA Growth ratio of MARKSANS PHARMA ?

The latest Core EBITDA Growth ratio of MARKSANS PHARMA is 17.68 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.68
Mar202427.69
Mar202332.55
Mar2022-13.16
Mar202179.82

How is Core EBITDA Growth of MARKSANS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 17.68
-36.15
Mar2024 27.69
-14.93
Mar2023 32.55
Positive
Mar2022 -13.16
Negative
Mar2021 79.82 -

Other Financial Ratios of MARKSANS PHARMA


Compare Core EBITDA Growth ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹10,178.9 Cr -0.8% -13.4% 7.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr -4.3% -3% -0.7% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -3.3% -7.4% 34.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 1.4% 10.1% 17.9% Stock Analytics
CIPLA ₹121,260.0 Cr -4.4% -0.5% 0.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -5.2% -5.7% -5.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-0.8%

-13.4%

7.9%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses